Could a daily supplement slow glaucoma damage?
NCT ID NCT05695027
First seen Nov 12, 2025 · Last updated May 20, 2026 · Updated 26 times
Summary
This study tests whether taking nicotinamide and pyruvate (N&P) supplements can help preserve vision in people with open-angle glaucoma. About 250 adults aged 35–85 will take either N&P or a placebo for 20 months, while continuing their standard glaucoma eye drops. The goal is to see if the supplements slow damage to the optic nerve and visual field.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY OPEN ANGLE GLAUCOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Columbia University Irving Medical Center - 622 W 168th St
New York, New York, 10032, United States
-
ColumbiaDoctors Ophthalmology - 880 Third Avenue
New York, New York, 10022, United States
-
Stanford University Department of Ophthalmology
Palo Alto, California, 94303, United States
Conditions
Explore the condition pages connected to this study.